Physician profile
Corey Warner
NPI 1710543889
$1,660.49
in general payments reported to CMS, 2019-2025
15 companies · $952 in 2025
The $952 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.56 · 2022: $73.16 · 2023: $279 · 2024: $281 · 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $478.27 | 2023-2025 | Entyvio |
| Abbvie INC. | $291.32 | 2025 | |
| Janssen Biotech, INC. | $272.14 | 2024-2025 | Tremfya, Stelara, Simponi |
| Regeneron Healthcare Solutions, INC. | $178.17 | 2022-2025 | Dupixent |
| Intercept Pharmaceuticals, INC. | $93.01 | 2023-2025 | Ocaliva |
| Ardelyx, INC. | $73.21 | 2025 | Ibsrela |
| Boston Scientific Corporation | $56.40 | 2023-2025 | General - Polypectomy |
| Medtronic, INC. | $55.55 | 2021-2025 | Interstim |
| Aimmune Therapeutics, INC. | $47.02 | 2025 | Vowst, Zenpep |
| Nestle Healthcare Nutrition INC. | $29.46 | 2022 | |
| Chiesi USA, INC. | $21.54 | 2021 | |
| Acacia Pharma INC | $17.35 | 2022 | |
| Braintree Laboratories, INC. | $17.00 | 2024 | Suflave, Sutab |
| Merck Sharp & Dohme LLC | $15.35 | 2021 | |
| Daiichi Sankyo INC. | $14.70 | 2023 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.